Pfizer Past Earnings Performance
Past criteria checks 4/6
Pfizer has been growing earnings at an average annual rate of 3.5%, while the Pharmaceuticals industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 0.9% per year. Pfizer's return on equity is 16.5%, and it has net margins of 27.6%.
Key information
3.5%
Earnings growth rate
3.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 0.9% |
| Return on equity | 16.5% |
| Net Margin | 27.6% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
We Think Pfizer (NSE:PFIZER) Can Stay On Top Of Its Debt
Aug 31
Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 25%
Aug 07Weak Statutory Earnings May Not Tell The Whole Story For Pfizer (NSE:PFIZER)
May 25Pfizer (NSE:PFIZER) Has A Pretty Healthy Balance Sheet
Feb 13Pfizer Limited's (NSE:PFIZER) Business Is Yet to Catch Up With Its Share Price
Jan 17Here's Why Pfizer (NSE:PFIZER) Can Manage Its Debt Responsibly
Mar 15A Look At The Intrinsic Value Of Pfizer Limited (NSE:PFIZER)
Jul 20Pfizer (NSE:PFIZER) Could Easily Take On More Debt
Mar 29Calculating The Fair Value Of Pfizer Limited (NSE:PFIZER)
Feb 07These 4 Measures Indicate That Pfizer (NSE:PFIZER) Is Using Debt Safely
Sep 23This Is The Reason Why We Think Pfizer Limited's (NSE:PFIZER) CEO Deserves A Bump Up To Their Compensation
Aug 12Are Institutions Heavily Invested In Pfizer Limited's (NSE:PFIZER) Shares?
Mar 10Why Dividend Hunters Love Pfizer Limited (NSE:PFIZER)
Feb 17Revenue & Expenses Breakdown
How Pfizer makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 22,381 | 6,179 | 4,425 | 0 |
| 30 Jun 24 | 22,247 | 6,085 | 3,457 | 0 |
| 31 Mar 24 | 21,932 | 5,513 | 4,337 | 0 |
| 31 Dec 23 | 22,192 | 5,021 | 3,998 | 0 |
| 30 Sep 23 | 23,010 | 5,228 | 4,021 | 0 |
| 30 Jun 23 | 23,632 | 6,849 | 3,948 | 0 |
| 31 Mar 23 | 24,248 | 6,239 | 3,935 | 0 |
| 31 Dec 22 | 24,041 | 6,201 | 4,334 | 0 |
| 30 Sep 22 | 24,583 | 6,133 | 4,514 | 0 |
| 30 Jun 22 | 24,571 | 4,452 | 4,762 | 0 |
| 31 Mar 22 | 26,110 | 6,126 | 4,784 | 0 |
| 31 Dec 21 | 25,961 | 5,873 | 4,720 | 0 |
| 30 Sep 21 | 25,137 | 5,847 | 4,564 | 0 |
| 30 Jun 21 | 24,728 | 5,731 | 4,353 | 0 |
| 31 Mar 21 | 22,404 | 4,976 | 4,266 | 0 |
| 31 Dec 20 | 22,058 | 5,001 | 4,555 | 0 |
| 30 Sep 20 | 21,505 | 4,979 | 4,514 | 0 |
| 30 Jun 20 | 21,221 | 5,208 | 3,628 | 0 |
| 31 Mar 20 | 21,517 | 5,091 | 4,531 | 0 |
| 31 Dec 19 | 21,853 | 5,156 | 4,628 | 0 |
| 30 Sep 19 | 21,609 | 5,085 | 4,565 | 0 |
| 30 Jun 19 | 21,136 | 4,500 | 4,483 | 0 |
| 31 Mar 19 | 20,815 | 4,291 | 4,416 | 0 |
| 31 Dec 18 | 20,658 | 4,241 | 4,377 | 0 |
| 30 Sep 18 | 20,085 | 3,794 | 4,196 | 0 |
| 30 Jun 18 | 20,599 | 3,947 | 3,142 | 0 |
| 31 Mar 18 | 19,685 | 3,601 | 4,210 | 0 |
| 31 Dec 17 | 18,866 | 3,236 | 3,911 | 0 |
| 30 Sep 17 | 19,215 | 2,987 | 4,130 | 0 |
| 30 Jun 17 | 18,860 | 3,139 | 3,090 | 0 |
| 31 Mar 17 | 19,663 | 3,368 | 4,086 | 0 |
| 31 Dec 16 | 20,453 | 2,737 | 4,452 | 0 |
| 30 Sep 16 | 20,595 | 2,711 | 4,357 | 0 |
| 30 Jun 16 | 20,350 | 2,276 | 4,237 | 0 |
| 31 Mar 16 | 20,123 | 3,050 | 4,068 | 0 |
| 31 Dec 15 | 19,649 | 1,680 | 5,755 | 0 |
| 30 Sep 15 | 19,334 | 1,460 | 5,603 | 0 |
| 30 Jun 15 | 19,018 | 861 | 5,583 | 0 |
| 31 Mar 15 | 18,531 | 698 | 3,594 | 0 |
| 31 Dec 14 | 16,632 | 1,137 | 4,199 | 9 |
| 30 Sep 14 | 11,078 | 1,380 | 3,817 | 9 |
| 30 Jun 14 | 11,118 | 2,194 | 1,722 | 0 |
| 31 Mar 14 | 11,103 | 2,209 | 3,936 | 0 |
| 31 Dec 13 | 11,161 | 2,230 | 4,163 | 79 |
Quality Earnings: PFIZER has high quality earnings.
Growing Profit Margin: PFIZER's current net profit margins (27.6%) are higher than last year (22.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PFIZER's earnings have grown by 3.5% per year over the past 5 years.
Accelerating Growth: PFIZER's earnings growth over the past year (18.2%) exceeds its 5-year average (3.5% per year).
Earnings vs Industry: PFIZER earnings growth over the past year (18.2%) did not outperform the Pharmaceuticals industry 20.5%.
Return on Equity
High ROE: PFIZER's Return on Equity (16.5%) is considered low.